Immunogen Inc
IMGN
IMGN was delisted on the 9th of February, 2024.
158 hedge funds and large institutions have $254M invested in Immunogen Inc in 2016 Q2 according to their latest regulatory filings, with 38 funds opening new positions, 53 increasing their positions, 32 reducing their positions, and 23 closing their positions.
94% more call options, than puts
Call options by funds: $1.73M | Put options by funds: $893K
66% more repeat investments, than reductions
Existing positions increased: 53 | Existing positions reduced: 32
65% more first-time investments, than exits
New positions opened: 38 | Existing positions closed: 23
10% more funds holding
Funds holding: 143 → 158 (+15)
61% less capital invested
Capital invested by funds: $651M → $254M (-$397M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Renaissance Technologies
New York
|
+$12.3M |
| 2 |
Millennium Management
New York
|
+$10.2M |
| 3 |
Morgan Stanley
New York
|
+$10M |
| 4 |
Macquarie Group
Sydney, NSW 2000,
Australia
|
+$8.65M |
| 5 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
+$7.56M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Primecap Management
Pasadena,
California
|
-$17.3M |
| 2 |
Fidelity Investments
Boston,
Massachusetts
|
-$14.4M |
| 3 |
BBA
Baker Bros. Advisors
New York
|
-$9.01M |
| 4 |
Invesco
Atlanta,
Georgia
|
-$8.14M |
| 5 |
GC
Guggenheim Capital
Chicago,
Illinois
|
-$1.94M |
IMGN Hedge Fund Activity: Q2 2016 in Review
158 of the 3,748 institutional investors tracked by Wall St. Rank reported a position in Immunogen Inc (IMGN) for Q2 2016, worth a combined $254M — down 61% from $651M a quarter earlier.
Buyers outnumbered sellers: 38 funds opened new IMGN positions and 23 closed out — a net gain of 15 holders — while 53 added to existing stakes and 32 trimmed.
The largest buyer was Renaissance Technologies, opening a new position worth an estimated $12.3M. The largest seller was Primecap Management, cutting an estimated $17.3M.
- 158 institutional investors held Immunogen Inc (IMGN) as of Q2 2016, up from 143 in Q1 2016.
- Funds reported $254M of Immunogen Inc stock for Q2 2016, down 61% quarter-over-quarter.
- 38 funds opened new Immunogen Inc positions in Q2 2016 and 23 closed out, a net change of +15 holders.
- The largest Immunogen Inc buyer in Q2 2016 was Renaissance Technologies, an estimated $12.3M added.
- The largest Immunogen Inc seller in Q2 2016 was Primecap Management, an estimated $17.3M sold.
Based on aggregated 13F filings for Q2 2016.